MX9701979A - Inhibicion de infeccion por rotavirus humano. - Google Patents

Inhibicion de infeccion por rotavirus humano.

Info

Publication number
MX9701979A
MX9701979A MX9701979A MX9701979A MX9701979A MX 9701979 A MX9701979 A MX 9701979A MX 9701979 A MX9701979 A MX 9701979A MX 9701979 A MX9701979 A MX 9701979A MX 9701979 A MX9701979 A MX 9701979A
Authority
MX
Mexico
Prior art keywords
inhibition
human
human rotavirus
rotavirus infection
kappa
Prior art date
Application number
MX9701979A
Other languages
English (en)
Other versions
MXPA97001979A (es
Inventor
Pradip Mukerji
Pedro Antonio Prieto
Amando Eug-Yong Seo
Jeffrey Harris Baxter
Richard Dale Cummings
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/308,883 external-priority patent/US5576300A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA97001979A publication Critical patent/MXPA97001979A/es
Publication of MX9701979A publication Critical patent/MX9701979A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un producto nutricional enteral que comprende ya sea k-caseína bovina o k-caseína humana a una concentracion mayor que la encontrada en leche humana o bovina y suficiente para inhibir la infeccion de células de mamífero por el rotavirus humano.
MX9701979A 1994-09-16 1995-05-05 Inhibicion de infeccion por rotavirus humano. MX9701979A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30888294A 1994-09-16 1994-09-16
US308882 1994-09-16
US08308883 1994-09-16
US08/308,883 US5576300A (en) 1994-09-16 1994-09-16 Method for inhibition of human rotavirus infection
PCT/US1995/005676 WO1996008269A1 (en) 1994-09-16 1995-05-05 Inhibition of human rotavirus infection

Publications (2)

Publication Number Publication Date
MXPA97001979A MXPA97001979A (es) 1997-06-01
MX9701979A true MX9701979A (es) 1997-06-28

Family

ID=26976500

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701979A MX9701979A (es) 1994-09-16 1995-05-05 Inhibicion de infeccion por rotavirus humano.

Country Status (7)

Country Link
EP (1) EP0784479A1 (es)
JP (1) JPH10505828A (es)
AU (1) AU711437B2 (es)
CA (1) CA2199707A1 (es)
MX (1) MX9701979A (es)
NZ (1) NZ285593A (es)
WO (1) WO1996008269A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001516570A (ja) * 1997-09-16 2001-10-02 ヴォルフ ゲオルグ フォースマン ビフィドゲニックペプチド類
EP1623717B1 (en) 2003-03-14 2018-08-29 Meiji Co., Ltd. Composition against rotavirus infection and process for producing the same
CA2624123C (en) 2005-09-30 2011-11-15 Morinaga Milk Industry Co., Ltd. Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JP2976349B2 (ja) * 1990-11-29 1999-11-10 雪印乳業株式会社 ｋ―カゼイングリコマクロペプチドの製造法
DK8892D0 (da) * 1992-01-23 1992-01-23 Symbicom Ab Humant proteingen
CA2148261A1 (en) * 1992-10-30 1994-05-11 Jerry A. Peterson Anti-diarrheic product and method of treating rotavirus-associated infection
DK2193D0 (es) * 1993-01-08 1993-01-08 Novo Nordisk As

Also Published As

Publication number Publication date
EP0784479A1 (en) 1997-07-23
WO1996008269A1 (en) 1996-03-21
AU2474495A (en) 1996-03-29
NZ285593A (en) 1999-03-29
AU711437B2 (en) 1999-10-14
JPH10505828A (ja) 1998-06-09
CA2199707A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
AU5072196A (en) Method for providing nutrition in a variety of compositional forms
TW326394B (en) Insulin formulation
CA2128078A1 (en) Nutritional product for trauma and surgery patients
GB2279262B (en) Infant incubator and humidifier
DK168790D0 (es)
GB2196954B (en) Method and device for destroying or inhibiting growth of bacteria
IL83089A0 (en) Method for the prevention of fusarium diseases in plants and microorganisms used for the same
HUP9900885A3 (en) Induction of male sterility in plants by expression of high levels of avidin
ES8705748A1 (es) Un procedimiento para la preparacion de una formula alimenticia baja en hidratos de carbono y alta en grasas.
EP0652285A3 (en) Lactic acid bacteria and fermented milk product.
EP0447893A3 (en) Culture dish package system and method of making
NZ237004A (en) Modification of seeds and plants by introduction of bacteria to produce reduction in stature of the plants
MX9701979A (es) Inhibicion de infeccion por rotavirus humano.
GB8823554D0 (en) Prophylaxis & treatment of gastro-intestinal disturbances in farm animals
AU2255288A (en) Asexual induction of heritable male sterility and apomixis in plants
GB9125052D0 (en) Culture of bone cells
CS4488A1 (en) Diagram of characteristics' group linearization and scaling
HK65992A (en) Allyltellurides and their use in the mocvd growth of group ii-vi epitaxial films
PL268520A1 (en) Specific fighting the growth of microorganisms and plant diseases
EP0503438A3 (en) Process for preparing agglomerates containing live and biologically active microorganisms
AU6480590A (en) Improvements in and relating to supported lactic acid bacteria cultures
CS189286A2 (en) Means for plants' growth and development regulation
HU905975D0 (en) Process envolving vacuum-technics for the production of microbiologically sterile fruit preparations while keeping their biological value and fulfilling special requirements
HU905974D0 (en) Process envolving vacuum-technics for the production of microbiologically sterile vegetable preparations while keeping their biological value and fulfilling special requirements
Oner Estimation of growth yields in aerobic and anaerobic cultures